PTOJ'SBIDBa (01-10)
`Doc code: IDS
`Approved for use through 071312012. OMB 0651-0031
`.
`.
`.
`_
`.
`.
`us. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Doc description. Information Disclosure Statement (IDS) Filed
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`3771
`Art Unit
`
`
`Examiner Name
`HOUSTON, ELIZABETH
`I PL2191843
`
`
`
`Application Number | 5551651
` EE, Jung Joo
`Filing Date '017—08—17
`I
`
`First Named Inventor
`
` Attorney Docket Number
`
`
`
`
`
` U.S.PATENTS -Remove
`
`Examiner Cite
`.
`.
`*
`InItIal
`No
`
`Patent Number
`
`Kind
`Code1
`
`Issue Date
`
`Name of Patentee or Applicant Pages,Columns,LInes where
`.
`Relevant Passages or Relevant
`of Cited Document
`Figures Appear
`
`101363
`
`ouji Nishizawa et al.
`
`Daniel T. Wallace et al.
`
`thicon Endo—Surgery, LLC
`
`hang Wook JEONG
`
`itan Medical Inc.
`
`
`
`
`
`
`
`
`
`Add
`If you wish to add additional US. Patent citation information please click the Add button.
`U.S.PATENT APPLICATION PUBLICATIONS
`-—
`
`Examiner Cite No Publication
`Initial*
`Number
`
`Publication
`Kind
`Code1 Date
`
`Name of Patentee or Applicant
`of cited Document
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`
`
`
`
`1
`
`EFS Web 2.1.17
`
`'0110112517
`
`'011-05-12
`
`'EINE;WiIIiam J.
`
`
`
`
`
`

`

`
`
`
`15551651
`
`
`Filing Date
`2017-08-17
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`First Named Inventor
`LEE, Jung Joo
`Art Unit
`| 3771
`Examiner Name
`HOUSTON, ELIZABETH
`Attorney Docket Number
`
` Application Number
`
`
`
`
`
`‘‘‘‘‘‘‘‘‘‘‘OOOOOOOOOOO_|_|_|_|_|_|_|C)C)_|C)NJ:--i=-(A)(A)4:-U10!“'5'd0')OOOOOOOOOOOOd00dO00OONdOC(.0U1-R—|U1000"OONhbOhNONU1on0')O0')CDU1N(DU1—|—|(A)—|NJ:-(D“'5'“'5'U1“'5'Nd“'5'J:-03on(A)OJ:-on0U10')U1U1"Nl
`
`I PL2191843 |eungWookCHOIetal.
`
`"slU14:-00N
`
`A1
`
`A1
`
`A1
`
`A1
`
`A1
`
`A1
`
`A1
`
`A1
`
`A1
`
`A1
`
`—l
`
`N
`
`A1
`
`EFS Web 2.1.17
`
`'006-01-26
`'011-05-05
`'007-09-06
`'008-03-13
`'015—01-29
`'014-11-27
`'013-01-10
`'013-06-06
`'014-11-27
`0'14-07-10
`0'12-01-05
`
`oojin LEE
`
`
`
`|
`| EONGChangWook
`|
`ishizawa;Kouji
`|
`
`| hangWookJeongetal.
`|
`|
`|TEFANCHIK,Davidetal.
`|
`| hangWookJEONGetal.
`
`
`
`

`

`
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`'0140350570
`
`
`15551651
`
`
`Filing Date
`2017-08-17
`
`
`First Named Inventor
`LEE, Jung Joo
`Art Unit
`| 3771
`Examiner Name
`HOUSTON, ELIZABETH
`Attorney Docket Number
`
`ung Joo LEE
`
` Application Number
` '014—11-27
`
`
`
`I PL2191843 If you wish to add additional U.S. Published Application citation information please click the Add button.Figures Appear
`
`
`
`'0110106145
`
`' 011-05-05
`
`hang Wook JEONG
`
`'0140114293
`
`014—04—24
`
`hang Wook JEONG et al.
`
`FOREIGN PATENT DOCUMENTS
`
`Add
`
`Examiner Cite
`
`Foreign Document
`Number3
`
`Name of Patentee or
`
`Applicant of cited
`Document
`
`Pages,Columns,Lines
`where Relevant
`
`Passages or Relevant
`
`' 01 0-220786
`
`' 004-122286
`
`UJIE MASAKATSU ET
`
`ouji Nishisawa et al.
`
`0—201 1-0014534
`
`EONG, CHANG WOOK
`
`0—201 1-0028613
`
`EONG, CHANG WOOK
`
`' 008-521485
`
`-$¥?§liifi§G'CAL
`
`0—2010—0099818
`
`2010—09—15
`
`IM, JlN HWAN
`
`EFS Web 2.1.17
`
`

`

`
`
`
`Application Number
`15551651
`
`
`Filing Date
`2017-08-17
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`-200666
`
`HOUSTON, ELIZABETH Attorney Docket Number
`| 3771
`
`
`First Named Inventor
`LEE, Jung Joo
`Art Unit
`Examiner Name
`
`2011—10—13
`
`ADHANI AKHIL J, et al.
`
`0—2009—01 19366
`
`2009—11—19
`
`UNG JU LEE et al.
`
`0—201 1-0005671
`
`2011—01—18
`
`
`
`A1
`
`2012—06—07
`
`yle Cobb et al.
`
`555_x_x_x(A)MdeaN43-BU'loE
`
`I PL2191843
`
`
`
`
`—l—l54(A)N
`
`2013—06—06
`
`TEFANCHIK, DAVID et
`u
`
`OGAMI MASAHIRO et al.
`
`EONG, CHANG WOOK
`t al.
`
`01064825
`
`1
`
`2011—09—14
`
`—l
`
`08173442
`
`1996—07—09
`
`—l 4:.
`
`5O9’DG) _\ §
`
`2006—03—09
`
`—l U'I
`
`vvvDOO—l—l—ldo:C)‘h-‘h-C)C)"-I00'h-I0U1_|—q_|—hJ:
`
`-521 703
`
`‘4
`
`EFS Web 2.1.1?
`
`3
`
`2010—03—18
`
`2013—05—30
`
`IVSMED INC.
`
`2011—07—28
`
`
`
`

`

`
`
`
`15551651
`
`
`Filing Date
`2017-08-17
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`First Named Inventor
`LEE, Jung Joo
`Art Unit
`| 3771
`Examiner Name
`HOUSTON, ELIZABETH
`Attorney Docket Number
`
` Application Number
`
`OC)9’KCD.4C!)
`
`2006-02-09
`
`
`
`URGERY INC
`
`0—1 364970
`
`B _\
`
`2014—02—1 8
`
`ung Joo LEE
`
`I PL2191843
`
`
`
`
`
`|\JO
`
`—|
`
`|\J|\J|\J|\J|\J014k00N
`
`|\J0')
`
`N-..4
`
`v
`
`0—2009—01 24828
`
`2009—12—03
`
`0—1 075294
`
`B1
`
`2011—10—19
`
`0—0956760
`
`DJ 1
`
`2010—05—12
`
`0—2010—01 18573
`
`2010—11—05
`
`0—201 3-0023755
`
`2013—03—08
`
`DC)(D‘hu d OO(.00')0')
`
`2009—08—1 3
`
`.eung Wook CHOI et al.
`
`0—201 3-0057250
`
`2013—05—31
`
`ung Joo LEE
`
`0—201 1-0028613
`
`201 1—03—21
`
`|\JCO
`
`0—2010—0099818
`
`2010—09—15
`
`in Whan YIM
`
`EFS Web 2.1.17
`
`

`

`
`
`
`Application Number
`15551651
`
`
`Filing Date
`2017-08-17
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`First Named Inventor
`LEE, Jung Joo
`Art Unit
`| 3771
`Examiner Name
`HOUSTON, ELIZABETH
`Attorney Docket Number
`I PL2191843
`
`
` If you wish to add additional Foreign Patent Document citation information please click the Add button
`
`
`
`
`
`
`
` Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item
`
` T5
`
`NON-PATENT LITERATURE DOCUMENTS
`
`(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`publisher, city and/or country where published.
`
`
`
`If you wish to add additional non-patent literature document citation information please click the Add button
`
`EXAMINER SIGNATURE
`
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 5 Applicant is to place a check mark here if
`English language translation is attached.
`
`
`
`EFS Web 2.1.17
`
`

`

`
`
`
`
`
`Application Number 15551651
`Filing Date 2017-08-17
`
`First Named Inventor LEE, Jung Joo
`
`Art Unit
`| 3771
`Examiner Name
`HOUSTON, ELIZABETH
`
` Attorney Docket Number
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`_
`_
`( Not for submissmn under 37 CFR 1.99)
`
`
`
`I PL2191843
`
`CERTIFICATION STATEMENT
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`El
`
`See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`X A certification statement is not submitted herewith.
`
`SIGNATURE
`
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`NamelPrint
`
`Registration Number
`
`l-9723
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form andlor suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.17
`
`

`

`Privacy Act Statement
`
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process andr'or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of Information Act requires disclosure of these record 5.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSA as part of that agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in
`an application which became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`
`
`
`
`
`
`EFS Web 2.1.17
`
`